Search alternatives:
significantly affect » significantly affected (Expand Search), significant effect (Expand Search), significant effects (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
affect decrease » effects decreased (Expand Search), largest decrease (Expand Search)
significantly affect » significantly affected (Expand Search), significant effect (Expand Search), significant effects (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
affect decrease » effects decreased (Expand Search), largest decrease (Expand Search)
-
2581
-
2582
-
2583
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2584
-
2585
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2586
-
2587
-
2588
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2589
-
2590
-
2591
-
2592
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2593
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2594
-
2595
-
2596
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2597
-
2598
-
2599
-
2600